Cargando…

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?

Detalles Bibliográficos
Autores principales:	Weatherald, Jason, Boucly, Athénaïs, Savale, Laurent, Jaïs, Xavier, Montani, David, Humbert, Marc, Sitbon, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885847/ https://www.ncbi.nlm.nih.gov/pubmed/33105080 http://dx.doi.org/10.1164/rccm.202009-3664LE

Ejemplares similares

Reply to Jin et al. and to Sun et al.
por: Boucly, Athénaïs, et al.
Publicado: (2021)

Acute decompensated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2017)

Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers
por: Boucly, Athénaïs, et al.
Publicado: (2022)

Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019)

External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry
por: Boucly, Athénaïs, et al.
Publicado: (2022)

The isobaric pulmonary arterial compliance in pulmonary hypertension
por: Chemla, Denis, et al.
Publicado: (2021)

Pulmonary hypertension associated with busulfan
por: Hagenburg, Jean, et al.
Publicado: (2021)

Sex and gender in pulmonary arterial hypertension
por: Cheron, Céline, et al.
Publicado: (2021)

Pulmonary hypertension associated with neurofibromatosis type 1
por: Jutant, Etienne-Marie, et al.
Publicado: (2018)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Reply to Jha
por: Montani, David, et al.
Publicado: (2022)

Pulmonary Hypertension Complicating Fibrosing Mediastinitis
por: Seferian, Andrei, et al.
Publicado: (2015)

Pulmonary arterial hypertension registries: past, present and into the future
por: Weatherald, Jason, et al.
Publicado: (2019)

An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants
por: Montani, David, et al.
Publicado: (2022)

Seeing the Forest for the (Arterial) Tree: Vascular Pruning and the Chronic Obstructive Pulmonary Disease Pulmonary Vascular Phenotype
por: Weatherald, Jason, et al.
Publicado: (2019)

A rare case of sarcoidosis-associated pulmonary hypertension in a patient exposed to silica
por: Bourlier, Delphine, et al.
Publicado: (2016)

Reply to Weatherald et al.: Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Badagliacca, Roberto, et al.
Publicado: (2021)

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
por: Launay, David, et al.
Publicado: (2018)

Factors predicting outcome after pulmonary endarterectomy
por: Tromeur, Cécile, et al.
Publicado: (2018)

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission
por: Jevnikar, Mitja, et al.
Publicado: (2021)

Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era
por: Savale, Laurent, et al.
Publicado: (2018)

French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Brenot, Philippe, et al.
Publicado: (2019)

COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study
por: Montani, David, et al.
Publicado: (2022)

Heritable pulmonary hypertension: from bench to bedside
por: Girerd, Barbara, et al.
Publicado: (2017)

Exertional dyspnoea in pulmonary arterial hypertension
por: Dumitrescu, Daniel, et al.
Publicado: (2017)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation
por: Montani, David, et al.
Publicado: (2021)

Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?
por: Le Pennec, Romain, et al.
Publicado: (2022)

Ventilatory efficiency in pulmonary vascular diseases
por: Weatherald, Jason, et al.
Publicado: (2021)

Role of Store-Operated Ca(2+) Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial Hypertension
por: Masson, Bastien, et al.
Publicado: (2021)

Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy
por: Montani, David, et al.
Publicado: (2014)

Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation
por: Beurnier, Antoine, et al.
Publicado: (2020)

Respiratory symptoms and radiological findings in post-acute COVID-19 syndrome
por: Jutant, Etienne-Marie, et al.
Publicado: (2022)

Non-Invasive Determination of Cardiac Output in Pre-Capillary Pulmonary Hypertension
por: Lador, Frédéric, et al.
Publicado: (2015)

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension
por: Girerd, Barbara, et al.
Publicado: (2010)

Pulmonary capillary haemangiomatosis: a distinct entity?
por: Weatherald, Jason, et al.
Publicado: (2020)

Ethical considerations of thoracic transplant and circulatory support during the COVID-19 pandemic: A closer look at pulmonary vascular disease
por: Bradley, Elisa A., et al.
Publicado: (2020)

Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease
por: Savale, Laurent, et al.
Publicado: (2019)

Hypoxemia during sleep and overnight rostral fluid shift in pulmonary arterial hypertension: a pilot study
por: Jutant, Etienne-Marie, et al.
Publicado: (2021)

Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus‐associated pulmonary arterial hypertension
por: Sanges, Sébastien, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r15op0blvo2g467ubm3i64niv8